We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.74% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vale
VALE
$63B
| $183M | 0.35% |
9,142,394
-3,364,873
| -27% | -$58.3M |
|
52
Robert Half
RHI
$4.29B
| $179M | 0.34% |
1,569,537
-196,448
| -11% | -$22.7M |
|
53
Amgen
AMGN
$223B
| $177M | 0.34% |
732,771
-154,224
| -17% | -$35.4M |
|
54
Synopsys
SNPS
$80.1B
| $176M | 0.33% |
529,378
-92,554
| -15% | -$28.9M |
|
55
Applied Materials
AMAT
$420B
| $173M | 0.33% |
1,312,027
-116,141
| -8% | -$16M |
|
56
Hershey
HSY
$36.6B
| $172M | 0.33% |
794,475
-43,404
| -5% | -$8.82M |
|
57
Oracle
ORCL
$432B
| $171M | 0.32% |
2,063,010
-530,470
| -20% | -$43M |
|
58
Chubb
CB
$135B
| $170M | 0.32% |
793,564
-61,425
| -7% | -$12.5M |
|
59
Lam Research
LRCX
$383B
| $169M | 0.32% |
3,135,810
+169,580
| +6% | +$9.87M |
|
60
Emerson Electric
EMR
$88.4B
| $166M | 0.31% |
1,691,905
-171,037
| -9% | -$16.2M |
|
61
Bio-Rad Laboratories Class A
BIO
$9.31B
| $164M | 0.31% |
290,598
+61,695
| +27% | +$37.2M |
|
|
62
Gilead Sciences
GILD
$166B
| $161M | 0.31% |
2,712,026
+1,482,141
| +121% | +$94.7M |
|
63
Waste Management
WM
$90.9B
| $160M | 0.3% |
1,006,954
-110,084
| -10% | -$16.7M |
|
64
Visa
V
$676B
| $158M | 0.3% |
710,640
-127,490
| -15% | -$27.6M |
|
65
Illinois Tool Works
ITW
$84.2B
| $156M | 0.3% |
744,780
-93,977
| -11% | -$21M |
|
66
Snap-on
SNA
$21.4B
| $156M | 0.3% |
758,487
+38
| +0% | +$8.02K |
|
67
Tyson Foods
TSN
$20.3B
| $154M | 0.29% |
1,729,249
+172,142
| +11% | +$15.7M |
|
68
Micron Technology
MU
$982B
| $153M | 0.29% |
1,984,727
+233,180
| +13% | +$19.9M |
|
69
KLA
KLAC
$254B
| $151M | 0.29% |
4,132,110
+363,420
| +10% | +$13.6M |
|
70
Infosys
INFY
$51B
| $150M | 0.29% |
6,044,325
-2,458,606
| -29% | -$58.3M |
|
71
Molina Healthcare
MOH
$10.4B
| $150M | 0.29% |
450,412
+49,918
| +12% | +$15.4M |
|
72
Capital One
COF
$134B
| $146M | 0.28% |
1,115,823
-132,972
| -11% | -$19.4M |
|
73
Mastercard
MA
$495B
| $144M | 0.27% |
403,635
-64,517
| -14% | -$23.2M |
|
74
Verizon
VZ
$194B
| $142M | 0.27% |
2,782,876
+49,687
| +2% | +$2.63M |
|
75
Owens Corning
OC
$12.3B
| $140M | 0.27% |
1,528,317
+195,704
| +15% | +$18M |
|
Similar funds
VGA
AQR Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
- AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.